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ABSTRACT
OBJECTIVE
To determine if first trimester maternal thyroid 
dysfunction is a critical determinant of child scholastic 
performance and overall educational attainment.
DESIGN
Prospective cohort study.
SETTING
Avon Longitudinal Study of Parents and Children 
cohort in the UK.
PARTICIPANTS
4615 mother-child pairs with an available first 
trimester sample (median 10 weeks gestation, 
interquartile range 8-12).
EXPOSURES
Free thyroxine, thyroid stimulating hormone, and 
thyroid peroxidase antibodies assessed as continuous 
measures and the seven clinical categories of 
maternal thyroid function.
MAIN OUTCOME MEASURES
Five age-specific national curriculum assessments 
in 3580 children at entry stage assessment at 54 
months, increasing up to 4461 children at their final 
school assessment at age 15.
RESULTS
No strong evidence of clinically meaningful 
associations of first trimester free thyroxine and 
thyroid stimulating hormone levels with entry stage 
assessment score or Standard Assessment Test scores 
at any of the key stages was found. Associations 
of maternal free thyroxine or thyroid stimulating 
hormone with the total number of General Certificates 
of Secondary Education (GCSEs) passed (range 0-16) 
were all close to the null: free thyroxine, rate ratio per 
pmol/L 1.00 (95% confidence interval 1.00 to 1.01); 
and thyroid stimulating hormone, rate ratio 0.98 (0.94 
to 1.02). No important relationship was observed 
when more detailed capped scores of GCSEs allowing 
for both the number and grade of pass or when 
language, mathematics, and science performance 
were examined individually or when all educational 
assessments undertaken by an individual from school 
entry to leaving were considered. 200 (4.3%) mothers 
were newly identified as having hypothyroidism or 
subclinical hypothyroidism and 97 (2.1%) subclinical 
hyperthyroidism or hyperthyroidism. Children 
of mothers with thyroid dysfunction attained an 
equivalent number of GCSEs and equivalent grades as 
children of mothers with euthyroidism.
CONCLUSIONS
Maternal thyroid dysfunction in early pregnancy 
does not have a clinically important association with 
impaired child performance at school or educational 
achievement.
Introduction
Overt and subclinical thyroid diseases affect up to 
10% of pregnancies depending on the laboratory 
reference range used.1 Thyroid hormone is essential 
for normal brain development, with both congenital 
thyroid deficiency and excessive exposure during fetal 
life associated with long term cognitive impairment.2 3 
As the developing fetus is dependent on maternal 
thyroid hormones until the late first trimester,4 
profound untreated maternal hypothyroidism in 
early pregnancy has been associated with an overall 
seven point reduction in child intelligence quotient.5 
Maternal subclinical hypothyroidism and isolated 
hypothyroxinaemia have also been associated with 
impairments in child intelligence quotient,2 5-7 
arithmetic skills,8 scholastic performance,9 and motor 
skills,5 7 as well as poorer reaction time,10 delays in 
attention,5 and increased attention deficit hyperactivity 
disorder symptoms.11 Maternal subclinical thyroid 
dysfunction has also been associated with an increased 
risk of miscarriage, gestational hypertension, pre-
eclampsia, gestational diabetes, and preterm birth,12 13 
and that treatment in some but not all studies improved 
outcomes,14-16 has prompted calls for universal thyroid 
function screening to facilitate early identification 
and treatment of both overt and subclinical 
disease.17  18 This is despite appropriately powered 
trials demonstrating that intervention with maternal 
levothyroxine treatment is not effective at notably 
improving perinatal or childhood cognitive outcomes 
for women with subclinical thyroid dysfunction.19-21
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WhAT IS AlReAdy knoWn on ThIS TopIC
Case-control and cohort studies have suggested that maternal thyroid 
dysfunction, and low levels of maternal thyroid hormone in particular, in the first 
trimester are associated with lower intellectual function and impaired cognitive 
processes in exposed children
Two randomised controlled trials of levothyroxine therapy in newly diagnosed 
mothers with hypothyroidism have not observed any decrement in cognitive 
function at age 3 or 5 compared compared with untreated mothers
Current clinical guidelines recommend treatment for mothers with thyroid 
dysfunction as long term intellectual effects are unknown
WhAT ThIS STudy AddS
Our study shows that maternal thyroid stimulating hormone levels and 
free thyroxine concentrations in the first trimester are not associated with 
performance in national curricular assessments from age 54 months to age 
15 years
Women with thyroid dysfunction in pregnancy can be reassured that their 
thyroid disease will not impact their child’s school performance or educational 
attainment
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Indeed, a large prospective randomised controlled 
trial which screened 21 846 mothers did not show 
any difference in intelligence quotient at age three 
between children of mothers with reduced thyroid 
function who were treated with levothyroxine or 
not.21 Similarly, a more recent trial which screened 
97 228 pregnant women showed that levothyroxine 
treatment of maternal subclinical hypothyroidism 
or isolated hypothyroxinaemia had no benefit on 
neurodevelopmental scores or cognitive function 
through to age five.20 Furthermore, screening and 
treatment of reduced maternal thyroid function 
did not alter birthweight or the incidence of 
preterm birth,20 21 which confirms current obstetric 
guidelines to not perform routine antenatal 
screening for hypothyroidism in pregnancy.22 23 
Not all professional bodies agree with continued 
endorsement of early initiation of treatment.12 18 
That these trials initiated treatment at a time when 
the fetal thyroid is functional, and did not stratify 
relative to thyroid peroxidase antibody status, 
has led to the suggestion that treatment was too 
late to be effective and not targeted appropriately. 
The trials were limited to the assessment of young 
children and used different measures of cognitive 
function, contributing to the lack of clarity.
Individual and overall cognitive domains have been 
shown to be predictive of educational attainment,24-26 
with the latter recognised as an important 
determinant of lifelong health, child and adult 
mortality, personal wealth, and national economic 
success.27 28 Assessment of first trimester maternal 
thyroid function in samples from the index pregnancy 
combined with long term follow-up of children with 
educational outcomes would address many of the 
criticisms levelled at the trials.29-32 We therefore 
examined, in the prospective Avon Longitudinal 
Study of Parents and Children cohort, if maternal 
gestational thyroid function is associated with 
child performance in repeat national standardised 
educational assessments through to the age of leaving 
secondary school.
Methods
Participants
The Avon Longitudinal Study of Parents and Children 
is a prospective birth cohort study investigating the 
health and development of children. The study has 
been described in full elsewhere.33-35 Women with 
expected delivery dates between 1 April 1991 and 31 
December 1992 were eligible for recruitment. Ethical 
approval was obtained from the Avon Longitudinal 
Study of Parents and Children’s Law and Ethics 
Committee and from the National Health Service 
local ethics committee. Figure 1 shows that a total 
of 14 541 women were enrolled and privides the 
numbers excluded for missing data, mothers treated 
with thyroid related drugs during the index pregnancy, 
multiple pregnancies, or with pre-existing thyroid 
disease. Supplementary table 1 shows the baseline 
characteristics of the entire Avon Longitudinal Study 
of Parents and Children cohort and those who did and 
did not have thyroid function assessed.
Thyroid function tests
Thyroid stimulating hormone levels, free thyroxine, 
and thyroid peroxidase anitbodies were assessed 
on stored serum samples using an Abbott Architect 
i2000 immunoassay analyser with functional 
sensitivity of 0.05 mIU/L or less. Interassay and 
intra-assay coefficients of variation were less than 
5% for all analytes. The limit of detection for thyroid 
stimulating hormone was 0.005 mIU/L. The limit of 
detection for free thyroxine was 0.3 pmol/L. A thyroid 
peroxidase antibody titre of 6 IU/mL or more was 
classed as positive, in accordance with UK National 
External Quality Assessment Service data. For thyroid 
peroxidase antibody negative women the 2.5th to 
97.5th centile for thyroid stimulating hormone levels 
was 0.070 mIU/L to 2.55 mIU/L, and the 2.5th to 
97.5th centile for free thyroxine levels was 12.53 
pmol/L to 22.78 pmol/L (0.97 ng/dL to 1.77 ng/dL).
We categorized women into clinical groups according 
to thyroid stimulating hormone and free thyroxine 
levels in the first trimester as defined by below the 2.5th 
and above the 97.5th centile in thyroid peroxidase 
antibody negative women; hypothyroid (thyroid 
stimulating hormone >97.5th and free thyroxine 
<2.5th); subclinical hypothyroid (>97.5th and 2.5th to 
97.5th); isolated hypothyroxinaemia (2.5th to 97.5th 
and <2.5th); isolated hyperthyroxinaemia (2.5th 
to 97.5th and >97.5th); subclinical hyperthyroid 
(<2.5th and 2.5th to 97.5); and hyperthyroid (<2.5th 
and >97.5th) (supplementary table 2). Additional 
sensitivity analyses were performed for hypothyroidism 
as defined by a thyroid stimulating hormone level 
above 10 mIU/L irrespective of free thyroxine 
level.22  23  36 Supplementary sensitivity analyses were 
performed with clinical categorisation according 
to thyroid stimulating hormone and free thyroxine 
gestational age-specific reference ranges in an iodine 
replete population.37 As recognised clinical categories 
were small in number, we performed further sensitivity 
analyses by combining hypothyroidism, subclinical 
hypothyroidism, and isolated hypothyroxinaemia 
categories to represent reduced maternal thyroid 
function (hypothyroid combined). Isolated 
hyperthyroxinaemia, subclinical hyperthyroidism, and 
hyperthyroidism were combined to represent increased 
maternal thyroid function (hyperthyroid combined).
Academic outcomes
Key stages assessment data linkage was conducted 
with the Department for Education educational 
attainment data provided for children included in the 
Avon Longitudinal Study of Parents and Children who 
attend publicly funded schools. In England, Wales and 
Northern Ireland, students aged between 4 and 16 
follow a national curriculum which is organised into 
blocks of years called key stages, undertaken at specific 
ages (supplementary table 3). Baseline assessment 
of language, reading, writing, mathematics, social, 
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problem solving, small motor, and large motor skills 
are performed before starting school education 
(entry stage). At the end of each key stage, the child’s 
performance is formally assessed as part of the program 
of National Curriculum Tests, which cover English, 
mathematics, and science. The final assessment (key 
stage 4) is the externally marked General Certificate of 
Secondary Education (GCSE) examination, which is the 
principal means of assessing educational attainment 
at the end of compulsory secondary education. 
Students study up to 12 subjects for GCSE. Subjects 
are graded individually on a scale of A* (highest) to G 
(lowest). Universities and employers usually regard A* 
to C as pass grades. For entry to further education, and 
apprenticeship schemes, the usual requirement would 
be five GCSE passes at A* to C, including both English 
and mathematics. These GCSE and preceding key stage 
scores are considered to be a true measure of academic 
performance.
Scores from entry stage were individually examined 
for each of the eight domains, with individual subject 
and overall scores assessed for key stage 1 to key 
stage 3. For key stage 2 and key stage 3, scores were 
available individually for English, mathematics, and 
science. The GCSE results were examined in three 
ways. First, we assessed the absolute number of GCSE 
passed at A* and A (any v none), passed (grades A* to 
C), and attempted (grades A* to G). Second, we utilised 
a GCSE score awarding a minimum of 16 points for 
a G grade with an additional 6 points for each grade 
increase, resulting in a maximum of 58 points for an 
A* grade. This was in turn analysed as either a total 
score or more usually a capped score summed over the 
eight best GCSE grades achieved.38 This capped score 
avoided conflating the number of GCSEs taken and 
the grades achieved and enabled analysis of effects 
across the full distribution of student ability. Lastly, 
we considered attainment of both GCSE and General 
National Vocational Qualifications (GNVQ), with 
scoring of GNVQ grades in a similar manner to GCSE 
grades and consideration of the total GCSE or GNVQ 
continuous score.
Statistical analysis
Spearman’s correlation coefficient was used to 
determine the association between thyroid measures. 
Thyroid stimulating hormone and thyroid peroxidase 
antibody were log-transformed and were approximately 
normally distributed with these transformations. For 
our main analyses, we examined both the continuous 
associations of thyroid stimulating hormone, free 
thyroxine, and thyroid peroxidase antibody and the 
effect of each clinical categories with educational 
outcomes. Linearity was checked using restricted cubic 
splines. Possible departure from linear associations 
between thyroid function measures and education 
outcomes were explored by adding quadratic terms to 
the model. We assessed the effect of clinical categories 
compared with euthyroid, using multivariable 
regression. Modified Park’s tests were used to determine 
the appropriate regression models (gamma, Poisson, 
and logistic) for discrete GCSE outcomes. We also 
assessed the effect of maternal thyroid function on an 
individual’s repeat educational outcomes scores. Total 
scores from key stages 1, 2, and 3, and capped GCSE 
scores were standardised by subtracting the mean and 
dividing by the standard deviation within each score. 
Linear mixed effects models were fitted with time as 
a fixed effect and a random effect of subject. In all of 
our primary analyses we adjusted for the following 
key confounders: maternal age, parity, ethnicity, body 
mass index, smoking status, alcohol consumption 
prepregnancy (none, fewer than one glass per week, or 
more than one glass per week), alcohol consumption 
during pregnancy (none, fewer than one glass per 
week, more than one glass per week), maternal social 
class, maternal education, and paternal education. 
In a sensitivity analyses we additionally adjusted for 
the following potential mediators: birthweight, child 
sex, child head circumference at birth, gestational age 
at birth, and mode of delivery. Of the 3580 to 4461 
mothers with complete thyroid function and education 
data, there were some participants with missing data on 
key confounders (supplementary table 4). This varied 
from 72 (1.5%) for maternal age to 1361 (29.4%) for 
paternal education. Missing values for covariates were 
imputed using multivariate multiple imputation, with 
five switching cycles and producing 100 imputation 
datasets. The regression models were performed on 
each imputed dataset and then the results were pooled 
using Rubin’s rules.39 40 The distributions of observed 
and imputed variables were similar (supplementary 
table 5). In this paper we present results from the 
imputed datasets. The results from those with complete 
data (n=1242 to 1952) are presented in supplementary 
table 1 for comparison. All analyses were performed 
with R version 3.1.3 or above, with packages: MICE 
version 2.22, nlme version 3.1-131, ggplot2 version 
0.9.3.1, and gplots version 2.3-45.
Patient involvement
No patients were involved in setting the research 
question or the outcome measures, nor were they 
involved in developing plans for recruitment, design, 
Enrolled pregnancies (n=14 541)
First trimester sample (n=5384)
Analyte values for thyroid stimulating hormone, free thyroxine, or thyroxine antibody available (n=4615)
Entry stage
(n=3580)
Key stage 1
(n=4324)
Key stage 2
(n=4378)
Key stage 3
(n=4141)
Key stage 4
(n=4461)
No rst trimester sample (n=9157)
Excluded:
  Taking thyroid drugs (n=24)
  Missing analyte values for thyroid
    stimulating hormone, free thyroxine,
    or thyroxine antibody (n=627)
  Multiple pregnancies (n=124)
Fig 1 | Study flow. Participants may have had more than one exclusion
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or implementation of the study. No patients were asked 
to advise on interpretation or writing up of results. 
Research findings from the Avon Longitudinal Study of 
Parents and Children are reported on the study website 
and disseminated to participants as part of mailed 
newsletters, email updates, and an annual participant 
meeting.
Results
Figure 1 shows that of the original 14 541 recruited 
to the Avon Longitudinal Study of Parents and 
Children cohort, 5384 had first trimester samples 
available for analysis, with thyroid stimulating 
hormone, free thyroxine, and thyroid peroxidase 
antibody status available for 4615 mothers. Thyroid 
function tests were performed on samples taken 
at a median of 10 weeks gestation (interquartile 
range 8-12 weeks) with 34 (0.74%) women 
newly identified as having hypothyroidism, 166 
(3.6%) subclinical hypothyroidism, 93 (2.0%) 
isolatedhypothyroxinaemia, 57 (1.2%) subclinical 
hyperthyroidism, and 40 (0.87%) hyperthyroidism 
based on the criteria we have used. An elevated thyroid 
peroxidase antibody was detected in 469 (10.2%) 
women. As anticipated, thyroid stimulating hormone 
and free thyroxine were negatively correlated (r −0.29, 
95% confidence interval −0.30 to −0.25), with thyroid 
stimulating hormone positively associated with thyroid 
peroxidase antibody titre (0.16, 0.13 to 0.18). Of the 
4614 women, 61.8% of women with hypothyroidism 
and 49.4% with subclinical hypothyroidism had an 
elevated thyroid peroxidase antibody, as compared 
with 8.2% with euthyroidism and 12.5% with 
hyperthyroidism. Table 1 shows the baseline thyroid 
function tests for each of the clinical categories, with 
the respective maternal and pregnancy characteristics 
presented in supplementary table 4.
Analysis using continuous data
Figure 1 shows that educational outcomes were 
available at school entry stage for 3580 children, at key 
stage 1 for 4324, at key stage 2 for 4378, at key stage 3 
for 4141, and at key stage 4 for 4461, with results 
available at all five time points for 3011 children. 
Table 2 shows that there was no strong evidence of a 
clinically important association of maternal thyroid 
stimulating hormone and free thyroxine with overall 
entry stage assessment score or Standard Assessment 
Test summary scores at any of the three key stages 
assessed. Similarly, we did not find evidence of 
important associations between maternal thyroid 
stimulating hormone and free thyroxine with the 
total number of GCSEs attempted, number passed, or 
grade at which they were passed (table 2). The same 
results were foundwhen continuous scores of GCSE or 
General National Vocational Qualifications attainment 
were assessed (supplementary table 5). Analysis of the 
individual components of the entry stage assessment 
did not show any association of maternal thyroid 
stimulating hormone, free thyroxine, or thyroid 
peroxidase antibody titre with language, reading, 
writing, mathematics, social, problem solving, 
small motor, or large motor skills (supplementary 
table 6). For both key stages 2 and 3 there were no 
associations of maternal thyroid function with English, 
mathematics, or science scores (supplementary 
table  7). There was an isolated positive association 
of thyroid peroxidase antibody titre with key stage 1 
score, but associations of thyroid peroxidase antibody 
titre with cognitive outcome at any of the other stages 
or any of the individual component scores were very 
close to the null. Associations of maternal thyroid 
stimulating hormone, free thyroxine, and thyroid 
peroxidase antibody with the educational outcomes 
were all close to the null value in the repeat measures 
analysis (supplementary table 8).
Analysis using clinical categories
Figure 2 shows that children of mothers who 
had undiagnosed hypothyroidism, subclinical 
hypothyroidism, isolated hypothyroxinaemia, isolated 
hyperthyroxinaemia, subclinical hyperthyroidism, or 
hyperthyroidism during pregnancy did not achieve 
different entry stage scores as compared with children 
of mothers with euthyroidism. Similarly, assessment 
scores for each stage did not differ between the 
categories of maternal thyroid function (fig 2). 
Figure  3 shows that assessment of GCSE attainment 
did not demonstrate any differences between clinical 
categories of maternal thyroid function. Similar results 
were found when GCSEs were expressed as continuous, 
capped, and binary outcomes. Similar results were 
Table 1 | First trimester thyroid function tests for each clinical category. Values are medians (interquartile range) unless stated otherwise
Characteristic
Hypothyroidism 
(n=34)
Subclinical  
hypothyroidism  
(n=166)
Isolated  
hypothyroxinaemia 
(n=93)
Euthyroidism 
(n=4169)
Isolated  
hyperthyroxinaemia 
(n=55)
Subclinical  
hyperthyroidism 
(n=57)
Hyperthyroidism 
(n=40)
Thyroid stimulating 
hormone (mIU/L)
5.12 (2.94-13.62) 3.22 (2.78-3.95) 1.16 (0.89-1.53) 0.97 (0.64-1.38) 0.80 (0.25-2.18) 0.04 (0.02-0.05) 0.02 (0.01-0.03)
Free thyroxine (pmol/L) 11.46  
(9.09-12.08)
15.30  
(14.13-16.59)
11.88  
(11.18-12.29)
16.21  
(14.91-17.62)
25.08  
(23.47-27.17)
19.30  
(18.05-20.87)
26.26  
(23.68-28.64)
Thyroid peroxidase 
antibody (IU/mL)
63.16  
(2.95-471.50)
5.69  
(2.02-143.40)
1.90  
(1.40-3.04)
1.92  
(1.34-2.97)
1.66  
(0.81-3.06)
2.23  
(1.63-3.34)
2.23  
(1.42-3.04)
No (%) of elevated 
thyroid peroxidase 
antibody*
21 (62) 82 (49) 6 (6) 343 (8) 6 (11) 6 (10) 5 (12)
*Titre ≥6 IU/mL was classed as elevated.
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obtained when we restricted hypothyroidism to 
women with thyroid stimulating hormone levels above 
10mIU/L (n=17 women) or categorised according to 
iodine replete reference ranges or collapsed clinical 
categories (see supplementary tables 11 and 12). The 
lack of association for individual and collapsed clinical 
categories was robust to adjustment for confounders 
and potential mediators irrespective of the gestational 
age specific reference ranges used for categorisation.
Findings from the complete case analyses were largely 
consistent with those from the imputation datasets, 
though with wider confidence intervals (supplementary 
tables 9 and 10). Findings were also similar when we 
adjusted for measured confounders and potential 
mediators (supplementary tables 13 to 15).
discussion
Clinical and epidemiological studies have previously 
suggested that maternal thyroid dysfunction in early 
pregnancy is associated with a range of adverse child 
outcomes.22 23 The most important of these is the poten-
tial contribution of maternal hypothyroidism to poor 
cognitive functioning in infancy and childhood.2 5-9 41 
In this prospective longitudinal study we did not ob-
serve association of maternal first trimester thyroid 
function with long term educational attainment or on 
any of the preceding school performance assessment 
stages. We were able to examine the associations of 
thyroid stimulating hormone, free thyroxine, and thy-
roid peroxidase antibody titre with meaningful educa-
tional outcomes. We examined thyroid measures both 
Table 2 | Association of first trimester maternal thyroid function with cognitive outcomes. Values are regression coefficients (95% confidence 
intervals) unless stated otherwise
Characteristic Entry stage Key stage 1 Key stage 2 Key stage 3
Key stage 4 no of GCSEs at grade
A* to A (OR) A to C (RR) A* to G (RGM)
Nobs (Nmiss)† 3580 (1035) 4324 (291) 4378 (237) 4141 (474) NA 4461 (154) NA
Age at assessment (years) 4.5 (4.2 to 4.8) 7.3 (7.1 to 7.7) 11.2 (10.9 to 
11.5)
14.1 (13.8 to 14.4) NA 15 (15 to 15) NA
Thyroid stimulating hormone 0.00 
 (−0.07 to 0.08)
0.07  
(−0.25 to 0.39)
0.10  
(−1.16 to 1.35)
1.05  
(−1.16 to 3.27)
0.87  
(0.70 to 1.07)
0.98  
(0.94 to 1.02)
1.00  
(0.97 to 1.03)
Free thyroxine 0.00 
 (−0.01 to 0.01)
0.01  
(−0.03 to 0.05)
−0.03  
(−0.18 to 0.13)
−0.08  
(−0.35 to 0.19)
1.01  
(0.99 to 1.04)
1.00  
(1.00 to 1.01)
1.00  
(1.00 to 1.00)
Thyroid peroxidase antibody 0.01 
 (−0.01 to 0.03)
0.01  
(0.01 to 0.21)
0.09  
(−0.48 to 0.29)
0.28  
(−0.42 to 0.97)
0.98  
(0.92 to 1.05)
1.00  
(0.99 to 1.01)
1.00  
(0.99 to 1.01)
Clinical categories:
 Hypothyroid −0.06 
 (−0.37 to 0.24)
−0.30  
(−1.58 to 0.98)
−1.97  
(−7.11 to 3.16)
0.66  
(−8.33 to 9.65)
0.25  
(0.05 to 1.17)
0.95  
(0.80 to 1.12)
1.04  
(0.92 to 1.18)
 Subclinical hypothyroid 0.16 
 (0.02 to 0.31)
0.73  
(0.13 to 1.32)
0.99  
(−1.29 to 3.27)
2.63  
(−1.52 to 6.79)
1.02  
(0.58 to 1.77)
1.02  
(0.95 to 1.10)
1.02  
(0.97 to 1.08)
 Isolated hypothyroxinaemia −0.04 
 (−0.23 to 0.16)
−0.55  
(−1.32 to 0.22)
−2.47  
(−5.57 to 0.62)
−5.46  
(−11.04 to 0.13)
0.81  
(0.48 to 1.37)
0.96  
(0.87 to 1.06)
1.00  
(0.93 to 1.08)
 Isolated hyperthyroxinaemia 0.06 
 (−0.18 to 0.29)
−0.58  
(−1.54 to 0.39)
−1.66  
(−5.61 to 2.28)
−7.06  
(−13.89 to −0.22)
0.92  
(0.50 to 1.70)
0.91  
(0.80 to 1.02)
0.91  
(0.83 to 1.00)
 Subclinical hyperthyroidism 0.01 
 (−0.27 to 0.28)
−0.45  
(−1.46 to 0.55)
−1.03  
(−5.08 to 3.02)
−2.15  
(−9.34 to 5.03)
1.06  
(0.55 to 2.04)
0.91  
(0.80 to 1.04)
0.91  
(0.83 to 1.01)
 Hyperthyroidism 0.03 
 (−0.25 to 0.31)
0.25  
(−0.91 to 1.41)
0.60  
(−3.96 to 5.17)
−1.47  
(−9.30 to 6.36)
0.98  
(0.45 to 2.11)
1.08  
(0.94 to 1.23)
1.07  
(0.96 to 1.19)
GCSEs=General Certificates of Secondary Education; OR=odds ratio; RR=rate ratio; RGM=ratio of geometric means; NA=not available.
†Number of observation (number missing).
Assessment (age in years)
Category
As
se
ss
m
en
t s
co
re
Entry stage (4.5)
0
20
40
60
80
120
100 Hypothyroidism
Isolated hypothyroxinaemia
Subclinical hypothyroidism
Euthyroidism
Isolated hyperthyroxinaemia
Hyperthyroidism
Key stage 1 (7.3) Key stage 2 (11.2) Key stage 3 (14.1)
Subclinical hyperthyroidism
Fig 2 | Mean assessment scores (95% confidence interval) relative to first trimester 
clinical categories of thyroid function
Grade
Category
No
 o
f G
CS
Es
 a
tta
in
ed
 a
t t
hi
s g
ra
di
ng
0
2
4
6
8
10
Hypothyroidism
Isolated hypothyroxinaemia
Subclinical hypothyroidism
Euthyroidism
Isolated hyperthyroxinaemia
Hyperthyroidism
A* - A A* - C A* - G
Subclinical hyperthyroidism
Fig 3 | Mean number of General Certificates of Secondary 
Education attainment (95% confidence interval) relative 
to first trimester clinical categories of thyroid function. 
Median age at assessment was 15 years (interquartile 
range 15-15)
RESEARCH
6 doi: 10.1136/bmj.k342 | BMJ 2018;360:k342 | the bmj
on a continuous scale and also in women who would 
have had a new diagnosis of hypothyroidism and hy-
perthyroidism if routine thyroid function testing had 
been performed. For all of these individual measures, 
and for concealed diagnoses of thyroid function, there 
was no consistent evidence of association with child 
educational attainment.
Comparison with other studies
Animal studies have shown that maternal 
hypothyroxinaemia in the first half of pregnancy can 
alter neurogenesis and lead to neuronal migration 
errors in the developing brain.42 Observational 
studies investigating the effect of low antenatal 
maternal free thyroxine concentrations on childhood 
cognitive functioning have reported inconsistent 
results and were of variable size (n=220 to 5049).2 9 
43-47 Severe maternal hypothyroxinaemia (free 
thyroxine <5th centile, n=11 of 220) was associated 
with a reduction of 14.1 points (95% confidence 
interval 5.9 to 22.0) in the Psychomotor Bayley Scales 
of Infant Development (BSID) at 10 months of age but 
not the mental BSID.43 A second study assessing 1761 
children reported a reduction of 3.4 (95% confidence 
interval 0.02 to 6.67) in the mental BSID at 14 months 
in the child of mothers with a free thyroxine below 
the 5th centile (n=82 of 1643) but the psychomotor 
BSID was unaffected.46 A third study reported that 
maternal free thyroxine below the 20th centile 
(n=57 of 287) was associated with a reduction in the 
Brunet–Lézine scale at 18 months of age.48 The most 
recent study assessing 3839 children suggested an 
inverted u shaped association between maternal free 
thyroxine and intelligence quotient at age six, with 
low and high free thyroxine associated with 1.4-3.8 
point reduction in child intelligence quotient.2 These 
studies were limited by assessment at one age. When 
repeat assessments were performed at 18 months and 
30 months (n=2926), maternal hypothyroxinaemia 
was associated with an increased risk of expressive 
language delay at both time points, and an increased 
risk of nonverbal cognitive delay at 30 months.45 
Conversely, other studies with longer follow up 
have not found an association between maternal 
hypothyroxinaemia and cognitive outcomes on repeat 
assessments at 6 months and 3 years (n=500),44 or at 
6, 12, 24, and 60 months (n=287).47 The largest study 
to date (n=5049) did not observe any differences in 
scholastic performance at age eight when children 
of mothers with thyroid dysfunction were compared 
with children of mothers with euthyroidism.9 At 
age 16 when the adolescents evaluated their own 
scholastic performance by questionnaire, adolescents 
of mothers with subclinical hypothyroidism and 
hyperthyroidism had higher adjusted odds of having 
self reported difficulties in mathematics, but no 
strong evidence for an association was observed for 
isolated hypothyroxinaemia.9 Distinct from previous 
series,2 addition of quadratic terms or use of repeat 
measures did not suggest a more complex relation of 
thyroid measures with educational outcomes.
The first of three randomised controlled trials on 
the effect of antenatal screening and treatment of 
mild thyroid dysfunction did not show a difference 
in childhood intelligence quotient at three years 
between children of treated (n=390) and untreated 
mothers (n=404)21. Post hoc analysis separately 
testing the effect of levothyroxine treatment on 
cognitive functioning in children of mothers with low 
free thyroxine levels only, also revealed no difference 
in outcomes.21 Similarly, screening and treatment of 
subclinical hypothyroidism (n=339 treated, n=338 
placebo) or isolated hypothyroxinaemia (265, 261) 
was not effective in improving neurodevelopmental 
outcomes through to age five years.20 The discordance 
between the smaller observational studies, the current 
study, and the randomised controlled trials data 
showing no effect of maternal thyroid dysfunction on 
child cognitive outcomes may reflect the small size of 
the earlier observational studies, possible publication 
bias, lack of adjustment for maternal confounders in 
those earlier studies, and use of different assessment 
tools, with even the widely used BSID being poorly 
related to later cognitive and educational outcomes.49 
Heterogeneous criteria used to define normal levels 
of thyroid stimulating hormone and free thyroxine 
during the first trimester may also contribute, with 
the threshold for defining normal thyroid stimulating 
hormone values varying from 2.2 mU/L to 4.8 
mU/L.43 45 48 We purposely did not utilise external 
reference ranges, as these may be assay specific, with 
current guidelines recommending derivation of local 
trimester specific reference ranges. This addresses the 
physiological changes in pregnancy that influence 
thyroid function, including increased renal iodine 
excretion, increased thyroxine binding globulin, 
decreased albumin concentrations, increased thyroid 
hormone production, and the thyroid stimulatory 
effects of human chorionic gonadotrophin.23 36 We 
excluded multiple pregnancies owing to their increased 
human chorionic gonadotrophin levels and performed 
additional sensitivity analyses using reference ranges 
specific to gestational age from an iodine replete 
population and the results were unchanged.
Strengths and weaknesses of this study
This is the first study linking maternal thyroid 
function to longer term and meaningful educational 
attainment. Our study has several strengths, including 
size, duration of follow-up, robust analyses including 
imputation to enable adjustment for confounders, use 
of an assay which has been validated for long term 
stored samples,50 consideration of an unscreened 
population incorporating undiagnosed maternal 
hypothyroidism and hyperthyroidism, and use of a 
national validated educational database to minimise 
loss of outcome data or bias owing to participation in a 
follow-up research clinic. 
We acknowledge several limitations. Maternal 
samples were not available for the whole Avon 
Longitudinal Study of Parents and Children cohort, 
however, this would only bias results if mothers with 
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available samples were systematically different from 
those without an available maternal sample, which 
they were not. Long term storage of maternal samples 
has been associated with an increase in thyroid 
peroxidase antibody titre but not that of thyroid 
stimulating hormone or free thyroxine.50 Our results 
were similar when we analysed our data continuously 
or when we derived clinical categories independent 
of thyroid peroxidase antibody status and just used 
thyroid stimulating hormone and free thyroxine 
concentrations. We acknowledge that we did not 
have repeat thyroid function tests across gestation, 
and were unable to examine whether patterns of 
thyroid stimulating hormone and free thyroxine across 
gestation contribute to educational attainment.51 
Similarly, maternal iodine status was only available for 
436 women with first trimester thyroid function data, 
limiting assessment of its contribution to long term 
educational outcomes. 
The national pupil database of government 
maintained establishments has 89.5% coverage of all 
English students nationally and 84.3% in the area of 
the Avon Longitudinal Study of Parents and Children 
cohort. We anticipate that key stage information 
was not available from the national pupil database 
owing to students living outside England or with 
insufficient information for linkage. As special care 
establishments are government maintained we do not 
anticipate that affected individuals have been lost to 
follow-up, similarly sixth form and further education 
colleges all contribute to the national pupil database 
ensuring maximal data coverage. Private schools 
do not contribute to the national pupil database, 
however, inclusion of privately educated students may 
be expected to attenuate any association owing to the 
extra support and improved GCSE results observed for 
these schools. 
We recognise that we assessed multiple associations 
and the isolated positive association of thyroid 
peroxidase antibody titre and key stage 1 scores may 
reflect a chance finding, particularly as there was 
no consistent association with performance at any 
other age of assessment. We were unable to assess 
subtle effects of maternal thyroid dysfunction on 
individual aspects of cognitive function such as 
executive functioning, memory, visual attention, and 
sensorimotor development. We would suggest the 
overall impact would be potentially small as there 
was no clinically important impact on academic 
achievement at any age. We acknowledge that family 
and parental factors, children’s dietary patterns and 
thyroid function, and education may have attenuated 
to the null any potential detrimental effect of maternal 
thyroid function on cognitive outcomes, but this would 
further support that maternal thyroid dysfunction does 
not have permanent consequences for long term child 
intellectual development.
Conclusion
Our results suggest that maternal thyroid dysfunction 
during early pregnancy is unlikely to be an important 
determinant of poor educational attainment in 
children.
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